BNP PARIBAS FINANCIAL MARKETS - HORIZON THERAPEUTICS PUB L ownership

HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 259 filers reported holding HORIZON THERAPEUTICS PUB L in Q2 2019. The put-call ratio across all filers is 1.60 and the average weighting 0.2%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of HORIZON THERAPEUTICS PUB L
ValueSharesWeighting
Q3 2023$11,382,161
-28.0%
98,385
-36.0%
0.02%
-25.0%
Q2 2023$15,811,233
-52.2%
153,731
-49.3%
0.02%
-56.5%
Q1 2023$33,066,801
+78.4%
302,976
+86.0%
0.05%
+64.3%
Q4 2022$18,532,558
-99.8%
162,852
-11.9%
0.03%
+55.6%
Q3 2022$11,435,044,000
-2.0%
184,764
+26.3%
0.02%0.0%
Q2 2022$11,665,618,000
-32.4%
146,259
-10.8%
0.02%
-21.7%
Q1 2022$17,253,598,000
-36.7%
163,992
-19.9%
0.02%
-39.5%
Q4 2021$27,270,500,000
+500.8%
204,755
+394.1%
0.04%
+533.3%
Q3 2021$4,538,899,000
-9.7%
41,436
-22.8%
0.01%
-14.3%
Q2 2021$5,024,722,000
-92.1%
53,660
-92.3%
0.01%
-92.5%
Q1 2021$63,878,061,000
+1289.6%
694,025
+1004.4%
0.09%
+933.3%
Q4 2020$4,596,819,000
+1078.3%
62,841
+1151.3%
0.01%
+800.0%
Q3 2020$390,109,000
-93.9%
5,022
-95.7%
0.00%
-90.9%
Q2 2020$6,431,940,000
+43.0%
115,724
-23.8%
0.01%
+22.2%
Q1 2020$4,496,434,000
+149.9%
151,804
+205.5%
0.01%
+200.0%
Q4 2019$1,798,959,000
+45.0%
49,695
+9.1%
0.00%
+50.0%
Q3 2019$1,240,789,000
-34.2%
45,567
-41.9%
0.00%
-50.0%
Q2 2019$1,886,424,00078,4050.00%
Other shareholders
HORIZON THERAPEUTICS PUB L shareholders Q2 2019
NameSharesValueWeighting ↓
Paulson & Co. 6,100,000$377,529,00027.63%
Kopp Family Office, LLC 542,543$33,578,00027.33%
Prosight Management, LP 303,000$18,753,00010.05%
Eversept Partners, LP 1,269,591$78,574,9876.81%
Octagon Capital Advisors LP 624,500$38,650,0006.67%
Avoro Capital Advisors LLC 5,125,000$317,186,0005.86%
1492 Capital Management LLC 119,836$7,417,0005.34%
Velan Capital Investment Management LP 68,829$4,260,0004.22%
Deep Track Capital, LP 1,462,800$90,533,0004.15%
Ally Bridge Group (NY) LLC 74,262$4,596,0003.03%
View complete list of HORIZON THERAPEUTICS PUB L shareholders